AXION BIOSYSTEMS HOLDING UK LIMITED
Executive Summary
AXION BIOSYSTEMS HOLDING UK LIMITED shows a fragile financial condition characterized by minimal net assets and high current liabilities owed to group companies. While compliant with filings and audited cleanly, its liquidity position is strained. Strengthening equity and improving intra-group financing terms are key steps to enhance financial health.
View Full Analysis Report →- Legal registered address
- 8 King Edward Street Oxford United Kingdom OX1 4HL Copied!
Latest financial results as of 2 August 2025- Fixed assets
- £4.75m
- Current creditors
- £4.75m
- Shareholders funds
- £147
View full financial accounts- Fixed assets
- £4.75m
- Current creditors
- £4.75m
- Shareholders funds
- £147
- Company number
- 13815981 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 30 September 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 23 December 2024
Next statement due by 6 January 2026
Nature of business (SIC)
64209 - Activities of other holding companies not elsewhere classified
Latest company documents
| Date | Description |
|---|---|
| 15/01/2515 January 2025 | Confirmation statement made on 2024-12-23 with updates |
| 01/10/241 October 2024 | Accounts for a small company made up to 2023-12-31 |
| 07/06/247 June 2024 | Termination of appointment of James Ross as a director on 2024-01-31 |
| 07/06/247 June 2024 | Appointment of Julien Bradley as a director on 2024-01-31 |
| 09/01/249 January 2024 | Confirmation statement made on 2023-12-23 with updates |
More Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company